Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
DARE — Dare Bioscience, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 14, 2026
REVENUE
$152455 -85.1%
NET MARGIN
-1967.7% -1826.9 PTS
EPS
-$0.21 -111.3%
FREE CASH FLOW
-$5.5M -546.1%

No summary has been written for this call yet.